Skip to main content
Erschienen in: Osteoporosis International 9/2012

01.09.2012 | Original Article

Normalization of cortical bone density in children and adolescents with hyperthyroidism treated with antithyroid medication

verfasst von: N. Numbenjapon, G. Costin, P. Pitukcheewanont

Erschienen in: Osteoporosis International | Ausgabe 9/2012

Einloggen, um Zugang zu erhalten

Abstract

Summary

We assessed bone size and bone density (BD) measurements using computed tomography (CT) in children and adolescents with hyperthyroidism treated with antithyroid medication. We found that cortical BD appeared to improve at 1 year and normalize at 2 years in all tested patients.

Introduction

Our previous study demonstrated that cortical BD in children and adolescents with untreated hyperthyroidism was significantly decreased as compared to age-, sex- and ethnicity-matched healthy controls. The present report evaluated whether attainment of euthyroidism by medical antithyroid treatment was able to improve or normalize cortical BD in these patients.

Methods

Anthropometrics and three-dimensional CT bone measurements including cross-sectional area (CSA), cortical bone area (CBA) and cortical BD at midshaft of the femur (cortical bone), and CSA and BD of L1 to L3 vertebrae (cancellous bone) in 15 children and adolescents after 1- and 2-year treatments with antithyroid medication were reviewed and compared to their pretreatment results.

Results

All patients were euthyroid at 1 and 2 years after medical antithyroid treatment. After adjusting for age, height, weight and Tanner stage, a significant increase in cortical BD in all patients (15/15) was found after 1 year of treatment (P < 0.001). Normalization of cortical BD was demonstrated in all tested patients (10/15) after 2 years. There were no significant changes in the other cancellous or cortical bone parameters.

Conclusion

Cortical BD was improved at 1 year and normalized at 2 years in hyperthyroid patients rendered euthyroid with antithyroid medication.
Literatur
1.
Zurück zum Zitat Vestergaard P, Mosekilde L (2002) Fractures in patients with hyperthyroidism: a nationwide follow-up study in 16,249 patients. Thyroid 12:411–419PubMedCrossRef Vestergaard P, Mosekilde L (2002) Fractures in patients with hyperthyroidism: a nationwide follow-up study in 16,249 patients. Thyroid 12:411–419PubMedCrossRef
2.
Zurück zum Zitat Tsai KS, Lai SM, Huang KM, Chieng PU, Su CT, Chen FW (1991) Decreased bone mineral density in patients with prolonged thyrotoxicosis before and after treatment. J Formos Med Assoc 90:250–255PubMed Tsai KS, Lai SM, Huang KM, Chieng PU, Su CT, Chen FW (1991) Decreased bone mineral density in patients with prolonged thyrotoxicosis before and after treatment. J Formos Med Assoc 90:250–255PubMed
3.
Zurück zum Zitat Karga H, Papapetrou PD, Korakovouni A, Papandroulaki F, Polymeris A, Pampouras G (2004) Bone mineral density in hyperthyroidism. Clin Endocrinol 61:466–472CrossRef Karga H, Papapetrou PD, Korakovouni A, Papandroulaki F, Polymeris A, Pampouras G (2004) Bone mineral density in hyperthyroidism. Clin Endocrinol 61:466–472CrossRef
4.
Zurück zum Zitat Numbenjapon N, Costin G, Gilsanz V, Pitukcheewanont P (2007) Low cortical bone density measured by computed tomography in children and adolescents with untreated hyperthyroidism. J Pediatr 150:527–530PubMedCrossRef Numbenjapon N, Costin G, Gilsanz V, Pitukcheewanont P (2007) Low cortical bone density measured by computed tomography in children and adolescents with untreated hyperthyroidism. J Pediatr 150:527–530PubMedCrossRef
5.
Zurück zum Zitat Wagasuki M, Wakao R, Tawata M, Gan N, Inoue M, Onaya T (1994) Change in bone mineral density in patients with hyperthyroidism after attainment of euthyroidism by dual energy x-ray absorptiometry. Thyroid 4:179–182CrossRef Wagasuki M, Wakao R, Tawata M, Gan N, Inoue M, Onaya T (1994) Change in bone mineral density in patients with hyperthyroidism after attainment of euthyroidism by dual energy x-ray absorptiometry. Thyroid 4:179–182CrossRef
6.
Zurück zum Zitat Siddiqi A, Burrin M, Noonan K, James I, Wood DF, Price CP, Monsan JP (1997) A longitudinal study of markers of bone turnover in Graves' disease and their value in predicting bone mineral density. J Clin Endocrinol Metab 82:753–759PubMedCrossRef Siddiqi A, Burrin M, Noonan K, James I, Wood DF, Price CP, Monsan JP (1997) A longitudinal study of markers of bone turnover in Graves' disease and their value in predicting bone mineral density. J Clin Endocrinol Metab 82:753–759PubMedCrossRef
7.
Zurück zum Zitat Nagasaka S, Sugimoto H, Nakamura T et al (1997) Antithyroid therapy improves bony manifestations and bone metabolic markers in patients with graves' thyrotoxicosis. Clin Endocrinol (Oxf) 47:215–221CrossRef Nagasaka S, Sugimoto H, Nakamura T et al (1997) Antithyroid therapy improves bony manifestations and bone metabolic markers in patients with graves' thyrotoxicosis. Clin Endocrinol (Oxf) 47:215–221CrossRef
8.
Zurück zum Zitat Rosen CJ, Adler RA (1992) Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. J Clin Endocrinol Metab 75:1531–1534PubMedCrossRef Rosen CJ, Adler RA (1992) Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. J Clin Endocrinol Metab 75:1531–1534PubMedCrossRef
9.
Zurück zum Zitat Mora S, Weber G, Marenzi K, Signorini E, Rovelli R, Proverbic MC, Chiumello G (1999) Longitudinal changes of bone density and bone resorption in hyperthyroid girls during treatment. J Bone Miner Res 14:1971–1977PubMedCrossRef Mora S, Weber G, Marenzi K, Signorini E, Rovelli R, Proverbic MC, Chiumello G (1999) Longitudinal changes of bone density and bone resorption in hyperthyroid girls during treatment. J Bone Miner Res 14:1971–1977PubMedCrossRef
10.
Zurück zum Zitat Lucidarme N, Ruiz JC, Czernidrow P, Leger J (2000) Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves' disease. J Pediatr 137:56–62PubMedCrossRef Lucidarme N, Ruiz JC, Czernidrow P, Leger J (2000) Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves' disease. J Pediatr 137:56–62PubMedCrossRef
11.
Zurück zum Zitat Gafni RI, Baron J (2004) Overdiagnosis of osteoporosis in children due to misinterpretation of dual-energy x-ray absorptiometry (DEXA). J Pediatr 144:253–257PubMedCrossRef Gafni RI, Baron J (2004) Overdiagnosis of osteoporosis in children due to misinterpretation of dual-energy x-ray absorptiometry (DEXA). J Pediatr 144:253–257PubMedCrossRef
12.
Zurück zum Zitat Pitukcheewanont P, Chen P (2005) Bone density measurements in children and adolescents: quantitative computed tomography versus dual-energy x-ray absorptiometry. Endocrinologist 15:232–239CrossRef Pitukcheewanont P, Chen P (2005) Bone density measurements in children and adolescents: quantitative computed tomography versus dual-energy x-ray absorptiometry. Endocrinologist 15:232–239CrossRef
13.
Zurück zum Zitat Hangartner TN, Johnston CC (1990) Influence of fat on bone measurements with dual-energy absorptiometry. Bone Miner 9:71–81PubMedCrossRef Hangartner TN, Johnston CC (1990) Influence of fat on bone measurements with dual-energy absorptiometry. Bone Miner 9:71–81PubMedCrossRef
14.
Zurück zum Zitat Wren TA, Liu X, Pitukcheewanont P, Gilsanz V (2005) Bone densitometry in pediatric populations: discrepancies in the diagnosis of osteoporosis by DXA and CT. J Pediatr 146:776–779PubMedCrossRef Wren TA, Liu X, Pitukcheewanont P, Gilsanz V (2005) Bone densitometry in pediatric populations: discrepancies in the diagnosis of osteoporosis by DXA and CT. J Pediatr 146:776–779PubMedCrossRef
15.
Zurück zum Zitat Tanner JM (1978) Physical growth and development. In: Forfar JO, Arnell CC (eds) Textbook of Pediatrics, 2nd edn. Churchill Livingstone, Edinburgh, pp 249–303 Tanner JM (1978) Physical growth and development. In: Forfar JO, Arnell CC (eds) Textbook of Pediatrics, 2nd edn. Churchill Livingstone, Edinburgh, pp 249–303
16.
Zurück zum Zitat Kuczmarski RJ, Ogden CL, Grummer-Strawn LM et al (2000) CDC growth charts: United States. Adv Data 314:1–27PubMed Kuczmarski RJ, Ogden CL, Grummer-Strawn LM et al (2000) CDC growth charts: United States. Adv Data 314:1–27PubMed
17.
Zurück zum Zitat Gilsanz V, Skaggs DL, Kovanlikaya A et al (1998) Differential effect of race on the axial and appendicular skeletons of children. J Clin Endocrinol Metab 83:1420–1427PubMedCrossRef Gilsanz V, Skaggs DL, Kovanlikaya A et al (1998) Differential effect of race on the axial and appendicular skeletons of children. J Clin Endocrinol Metab 83:1420–1427PubMedCrossRef
18.
Zurück zum Zitat Gilsanz V, Nelson DA (2003) Childhood and adolescence. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 5th edn. American Society for Bone and Mineral Research, Washington, D.C., pp 71–80 Gilsanz V, Nelson DA (2003) Childhood and adolescence. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 5th edn. American Society for Bone and Mineral Research, Washington, D.C., pp 71–80
19.
Zurück zum Zitat Pitukcheewanont P, Safani D, Church J, Gilsanz V (2005) Bone measures in HIV-1 infected children and adolescents: disparity between quantitative computed tomography and dual-energy x-ray absorptiometry measurements. Osteoporos Int 16:1393–1396PubMedCrossRef Pitukcheewanont P, Safani D, Church J, Gilsanz V (2005) Bone measures in HIV-1 infected children and adolescents: disparity between quantitative computed tomography and dual-energy x-ray absorptiometry measurements. Osteoporos Int 16:1393–1396PubMedCrossRef
20.
Zurück zum Zitat Mosekilde L, Melsen F (1978) Effect of antithyroid treatment on calcium–phosphorus metabolism in hyperthyroidism. II: bone histomorphometry. Acta Endocrinol 87:751–758PubMed Mosekilde L, Melsen F (1978) Effect of antithyroid treatment on calcium–phosphorus metabolism in hyperthyroidism. II: bone histomorphometry. Acta Endocrinol 87:751–758PubMed
21.
Zurück zum Zitat Vestergaard P, Rejnmark L, Mosekilde L (2005) Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk. Calcif Tissue Int 77:139–144PubMedCrossRef Vestergaard P, Rejnmark L, Mosekilde L (2005) Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk. Calcif Tissue Int 77:139–144PubMedCrossRef
22.
Zurück zum Zitat Langdahl BL, Loft AG, Eriksen EF, Mosekilde L, Charles P (1996) Bone mass, bone turnover, body composition, and calcium homeostasis in former hyperthyroid patients treated by combined medical therapy. Thyroid 6:161–168PubMed Langdahl BL, Loft AG, Eriksen EF, Mosekilde L, Charles P (1996) Bone mass, bone turnover, body composition, and calcium homeostasis in former hyperthyroid patients treated by combined medical therapy. Thyroid 6:161–168PubMed
23.
Zurück zum Zitat Grant DJ, McMurdo ME, Mole PA, Paterson CR (1995) Is previous hyperthyroidism still a risk factor for osteoporosis in post-menopausal women? Clin Endocrinol 43:339–345CrossRef Grant DJ, McMurdo ME, Mole PA, Paterson CR (1995) Is previous hyperthyroidism still a risk factor for osteoporosis in post-menopausal women? Clin Endocrinol 43:339–345CrossRef
24.
Zurück zum Zitat Pantazi H, Papapetrou PD (2000) Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. J Clin Endocrinol Metab 85:1099–1106PubMedCrossRef Pantazi H, Papapetrou PD (2000) Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. J Clin Endocrinol Metab 85:1099–1106PubMedCrossRef
25.
Zurück zum Zitat Brockstedt H, Kassem M, Eriksen EF, Mosekilde L, Melsen F (1993) Age- and sex-related changes in iliac cortical bone mass and remodeling. Bone 14:681–691PubMedCrossRef Brockstedt H, Kassem M, Eriksen EF, Mosekilde L, Melsen F (1993) Age- and sex-related changes in iliac cortical bone mass and remodeling. Bone 14:681–691PubMedCrossRef
26.
Zurück zum Zitat Parfitt AM, Travers R, Rauch F, Glorieux FH (2000) Structural and cellular changes during bone growth in healthy children. Bone 27:487–494PubMedCrossRef Parfitt AM, Travers R, Rauch F, Glorieux FH (2000) Structural and cellular changes during bone growth in healthy children. Bone 27:487–494PubMedCrossRef
27.
Zurück zum Zitat Wong GW, Lai J, Cheng PS (1999) Growth in childhood thyrotoxicosis. Eur J Pediatr 158:776–779PubMedCrossRef Wong GW, Lai J, Cheng PS (1999) Growth in childhood thyrotoxicosis. Eur J Pediatr 158:776–779PubMedCrossRef
28.
Zurück zum Zitat Schlesinger S, MacGillivray MH, Munschauer RW (1973) Acceleration of growth and bone maturation in childhood thyrotoxicosis. J Pediatr 83:233–236PubMedCrossRef Schlesinger S, MacGillivray MH, Munschauer RW (1973) Acceleration of growth and bone maturation in childhood thyrotoxicosis. J Pediatr 83:233–236PubMedCrossRef
29.
Zurück zum Zitat Lazar L, Kalter-Leibovici O, Pertzelan A, Weintrob N, Josefsberg Z, Phillip M (2000) Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients. J Clin Endocrinol Metab 85:3678–3682PubMedCrossRef Lazar L, Kalter-Leibovici O, Pertzelan A, Weintrob N, Josefsberg Z, Phillip M (2000) Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients. J Clin Endocrinol Metab 85:3678–3682PubMedCrossRef
30.
Zurück zum Zitat Jaruratanasirikul S, Sriplung H (2006) Growth pattern of childhood thyrotoxicosis: longitudinal follow-up to final height. J Med Assoc Thai 89:1396–1399PubMed Jaruratanasirikul S, Sriplung H (2006) Growth pattern of childhood thyrotoxicosis: longitudinal follow-up to final height. J Med Assoc Thai 89:1396–1399PubMed
Metadaten
Titel
Normalization of cortical bone density in children and adolescents with hyperthyroidism treated with antithyroid medication
verfasst von
N. Numbenjapon
G. Costin
P. Pitukcheewanont
Publikationsdatum
01.09.2012
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 9/2012
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-011-1867-8

Weitere Artikel der Ausgabe 9/2012

Osteoporosis International 9/2012 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.